Manchester Capital Management’s Chemed CHE Stock Holding History

Manchester Capital Management’s Portfolio CHE Stock Details CHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-6	Closed	-$2.57K	–	1327
2025 Q4	$2.57K	Buy	6 +2	+50%	+$871	﹤0.01%	976
2025 Q3	$1.79K	Buy	4 +3	+300%	+$1.36K	﹤0.01%	1095
2025 Q2	$487	Hold	1	–	–	﹤0.01%	1112
2025 Q1	$616	Hold	1	–	–	﹤0.01%	1075
2024 Q4	$530	Sell	1 -1	-50%	-$564	﹤0.01%	1077
2024 Q3	$1.2K	Hold	2	–	–	﹤0.01%	1023
2024 Q2	$1.09K	Buy	2 +1	+100%	+$573	﹤0.01%	1002
2024 Q1	$642	Hold	1	–	–	﹤0.01%	920
2023 Q4	$585	Hold	1	–	–	﹤0.01%	898
2023 Q3	$520	Hold	1	–	–	﹤0.01%	900
2023 Q2	$542	Hold	1	–	–	﹤0.01%	873
2023 Q1	$538	Hold	1	–	–	﹤0.01%	994
2022 Q4	$510	Buy	+1	New	+$487	﹤0.01%	906
2022 Q2	–	Sell	-3	Closed	-$2K	–	994
2022 Q1	$2K	Buy	+3	New	+$1.44K	﹤0.01%	801
2021 Q4	–	Sell	-6	Closed	-$3K	–	1020
2021 Q3	$3K	Sell	6 -8	-57%	-$3.77K	﹤0.01%	774
2021 Q2	$7K	Buy	+14	New	+$6.72K	﹤0.01%	526

Other funds holding CHE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return

Manchester Capital Management's CHE Position: Q1 2026 in Review

Manchester Capital Management sold out of Chemed (CHE) in Q1 2026, closing a stake of 6 shares — an estimated $2.57K sold.

Manchester Capital Management first reported a position in CHE in Q2 2021 and held it in 16 quarters. The position peaked at $7K in Q2 2021. 489 funds tracked by Wall St. Rank hold CHE as of Q1 2026.

Manchester Capital Management reported no remaining Chemed position as of Q1 2026 after selling out during the quarter.
Manchester Capital Management sold 6 Chemed shares in Q1 2026, an estimated $2.57K.
Manchester Capital Management first reported a position in Chemed in Q2 2021 and held it in 16 quarters.
Manchester Capital Management's Chemed position peaked at $7K in Q2 2021.
489 funds tracked by Wall St. Rank held Chemed as of Q1 2026.

Based on Manchester Capital Management's 13F filing for Q1 2026, filed 11 May 2026.